BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹335 Cr | ₹320 Cr | ₹311 Cr | ₹261 Cr | ₹240 Cr |
What is the latest Total Liabilities ratio of BAL PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹335 Cr |
| Mar2024 | ₹320 Cr |
| Mar2023 | ₹311 Cr |
| Mar2022 | ₹261 Cr |
| Mar2021 | ₹240 Cr |
How is Total Liabilities of BAL PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹335 Cr | 4.83 | |
| Mar2024 | ₹320 Cr | 2.84 | |
| Mar2023 | ₹311 Cr | 19.37 | |
| Mar2022 | ₹261 Cr | 8.52 | |
| Mar2021 | ₹240 Cr | - | |
Compare Total Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹126.7 Cr | -0.4% | -10.7% | -22.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -0.4% |
-10.7% |
-22.7% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses